Different metabolic parameters of F18-fluorodeoxyglucose uptake of positron emission tomography/computed tomography in the initial assessment of lymphomas, an observational cross-sectional study

Faculty Medicine Year: 2022
Type of Publication: ZU Hosted Pages:
Authors:
Journal: SECI onclogy SECI onclogy Volume:
Keywords : Different metabolic parameters , F18-fluorodeoxyglucose uptake , positron    
Abstract:
F18 fluoro-deoxy-glucose positron emission tomography/computed tomography (F18-FDG-PET/CT) now is the gold standard imaging for the initial assessment of lymphoma. The most commonly used parameter for the assessment of the activity is the maximum standardized uptake value (SUV max). Metabolic tumor value (MTV) and total lesion glycolysis (TLG) are other metabolic PET/CT parameters that assess the size of a lesion and behavior. In this study, we analyzed the data extracted from a PET/CT study done for initial assessment, to know if there is a difference in the metabolic parameters (SUV max, MTV, and TLG) of the most active lesion between the two main pathological types of lymphoma. Patients and Methods This study included 73 lymphoma patients, all of whom had undergone F18-FDG PET/CT as an initial assessment. The images of these patients were interpreted by two experienced nuclear medicine specialists. First, visual assessment was done to detect the presence of any extra-nodal lesions, the distribution of the positive LN groups, and the distribution of the most active lesion Semi-quantitative parameters were calculated using three dimensional volume of interest (VOI) around the most active lesion either nodal or extra-nodal (SUV max, MTV, and TLG) to detect if there is any statistically significant difference between Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). Results Of the 73 patients included in this study, 40 patients had HL and 33 patients had NHL. There was a significant difference in presence of the extra-nodal lesions, distribution of nodal lesions, and the distribution of most active lesions between the two groups (P-value 0.017 and 0.04 respectively). There were no statistically significant differences between the 2 main groups (HL and NHL) regarding SUV max, TLG, and MTV (p-values were 0.339, 0.19, 0.333 respectively). Conclusion: Our study finds that the presence of the extra-nodal lesions, distribution of nodal lesions, and the distribution of most active lesions have a significant difference between HL and NHL, but metabolic parameters (SUV max, TLG, and MTV) have no significant differences between the two groups. Keywords F18 -FDG PET/CT, initial lymphoma, metabolic parameters, SUV max, TLG, MTV
   
     
 
       

Author Related Publications

  • Heba Mounir AbdelHamid, "Comparison of Prostate-specific Membrane Antigen Reporting and Data System Version 1.0 versus 2.0 for Prostate Cancer Assessment", RSNA, 2025 More
  • Heba Mounir AbdelHamid, "Comparative study between 18F FDG-PET/CT and whole body MRI DWIBS in assessment of recurrent breast cancer Indian", .Indian J. Nucl. Me, 2019 More
  • Heba Mounir AbdelHamid, "Radical Conformal Radiotherapy versus Two-Dimensional Radiotherapy in Oligometastatic Breast Cancer Patients:Response, Toxicity, and Survival", Zagazig University medical J, 2020 More
  • Heba Mounir AbdelHamid, "Quantitative scintigraphy in discriminating sacroiliac joint physiological and pathological uptake.", Egyptian J of radiology and nuclear medicine, 2021 More
  • Heba Mounir AbdelHamid, "Additive value of 18FDG‑PET/CT to positive 131I whole body scan in recurrent differentiated thyroid cancer patients with potential influence on treatment strategy: single Egyptian center experience", Egyptian J of radiology and nuclear medicine, 2022 More

Department Related Publications

  • Ibrahim Mansour Ibrahim Nasr, "Additive Value of F18-FGD-PET/CT in Pancreatic Mass Evaluation", Egyptian journal of nuclear Medicine, 2016 More
  • Ahmed Ali Eliwa esmail, "68Ga-PSMA PET/CT in Patients with Rising Prostatic-Specific Antigen After Definitive Treatment of Prostate Cancer: Detection Efficacy and Diagnostic accuracy", ELSEVIER, 2018 More
  • Mustafa Mohamed Mahmoud Mohammed Tom, "POSTMASTECTOMY HYPOFRACTIONATED IRRADIATION IN EGYPTIAN PATIENTS WITH BREAST CANCER: ZAGAZIG UNIVERSITY EXPERIENCE", International Journal of Cancer and Oncology, (2018) Vol 5:1 : 8- 12.  , 2018 More
  • Mohamed Abdel Gawad Souleiman, "clincopathologicall and prognostic value of immunohistochemical expression of cd44 (stem cell marker) and ki67 in serous ovarian cancer", Journal of Clinical and Diagnostic Research, 2020 More
  • Reham Amien Elsayed Salem, "Concordance Between ER, PR, HER2 neu Receptors Before and After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer التوافق بين مستقبلات الاستروجين، البروجيستيرون، و هير-2 نيو قبل وبعد العلاج الكيميائي المساعد في سرطان الثدي المتقدم محليًا", Forum of clinical oncology, 2020 More
Tweet